List of insiders holdings for Nuvation Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Hung David PRESIDENT AND CEO 10% Owner | 2024-03-26 20:15:27 | 61,269,498 0 | 61,269,498 | Form 13D |
| Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. 10% Owner | 2023-02-13 16:40:55 | 15,072,340 0 | 15,072,340 | Form 13D |
| Omega Fund V L.P. Omega Fund IV GP L.P. Omega Fund V GP Manager Ltd. 10% Owner | 2023-02-13 16:40:55 | 15,072,340 0 | 15,072,340 | Form 13D |
| Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari DOIG MICHELLE 10% Owner | 2023-02-13 16:40:55 | 15,072,340 0 | 15,072,340 | Form 13D |
| NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 2023-09-22 15:44:37 | 0 12,674,775 | 12,674,775 | Form 4/A |
| NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Panacea Holdings LLC Biotech Opportunity GP LLC Director | 2021-04-13 17:55:30 | 0 6,721,252 | 6,721,252 | Form 4 |
| Cui Xiangmin Director | 2024-04-11 21:01:01 | 0 4,183,002 | 4,183,002 | Form 4 |
| Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | 2024-04-11 18:30:40 | 2,253,957 550,758 | 2,804,715 | Form 4 |
| Templeman Thomas SVP, Pharmaceutical Ops | 2021-02-12 17:48:19 | 797,870 0 | 797,870 | Form 4 |
| Yurasov Sergey Chief Medical Officer | 2021-02-12 17:46:31 | 797,870 0 | 797,870 | Form 4 |
| Sjogren Colleen Chief Commercial Officer | 2024-04-11 18:31:25 | 750,000 0 | 750,000 | Form 4 |
| Mashal Robert Director | 2024-01-10 16:22:44 | 741,179 0 | 741,179 | Form 4 |
| PA Co-Investment LLC Cowen Investments II LLC RCG LV Pearl LLC COWEN INC. SOLOMON JEFFREY M 10% Owner | 2020-06-30 19:39:01 | 718,750 0 | 718,750 | Form 3 |
| Fox Jennifer A. Chief Financial Officer | 2023-03-02 17:58:54 | 604,481 0 | 604,481 | Form 4 |
| Hanley David C. CHIEF TECHNICAL OPERATIONS | 2024-03-04 16:40:00 | 512,000 0 | 512,000 | Form 4 |
| Markel Stacy CHIEF PEOPLE OFFICER | 2024-03-04 17:24:09 | 510,591 0 | 510,591 | Form 4 |
| Liu Dongfang CHIEF MEDICAL OFFICER | 2024-03-04 16:27:28 | 506,000 0 | 506,000 | Form 4 |
| Wentworth Kerry CHIEF REGULATORY OFFICER | 2024-03-04 17:25:49 | 500,000 0 | 500,000 | Form 4 |
| Hattersley Gary CHIEF SCIENTIFIC OFFICER | 2024-03-04 16:33:32 | 500,000 0 | 500,000 | Form 4 |
| Bazemore Robert B Director | 2023-05-17 17:04:20 | 366,744 0 | 366,744 | Form 4 |
| WELCH DANIEL G Director | 2023-05-17 17:15:35 | 366,744 0 | 366,744 | Form 4 |
| VERNON W ANTHONY Director | 2023-05-17 17:14:55 | 366,744 0 | 366,744 | Form 4 |
| FALBERG KATHRYN E Director | 2023-05-17 17:13:34 | 366,744 0 | 366,744 | Form 4 |
| BLICKENSTAFF KIM D Director | 2023-05-17 17:12:58 | 366,744 0 | 366,744 | Form 4 |
| Makunje Moses SEE REMARKS | 2024-03-04 17:22:05 | 250,000 0 | 250,000 | Form 4 |
| Hasnain Faheem Director | 2021-02-26 19:00:28 | 55,000 0 | 55,000 | Form 4 |
| Sharp Shalini Director | 2021-02-26 19:02:07 | 35,000 0 | 35,000 | Form 4 |
| BRADBURY DANIEL Director | 2021-02-26 19:01:24 | 25,000 0 | 25,000 | Form 4 |
| COOPER GRAHAM K Director | 2021-02-26 18:59:18 | 25,000 0 | 25,000 | Form 4 |
| Marriott Sarah Secretary | 2020-06-30 18:04:29 | 0 0 | 0 | Form 3 |
| Stout Caroline Chief Investment Officer | 2020-06-30 18:12:42 | 0 0 | 0 | Form 3 |
| Platshon Scott Chief Operating Officer | 2020-06-30 18:09:42 | 0 0 | 0 | Form 3 |
| Perlen Scott Chief Financial Officer | 2020-06-30 18:05:47 | 0 0 | 0 | Form 3 |